We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$322M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97

Sector Composition

Rank Sector Weight
1 Healthcare 14.05%
2 Technology 13.96%
3 Financials 13.95%
4 Industrials 9.13%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEO
726
DELISTED
CNOOC Limited
CEO
$14.5M 0.01%
81,000
+1,800
+2% +$305K
NNN icon
727
NNN REIT
NNN
$9.04B
$14.4M 0.01%
387,055
+1,530
+0.4% +$53.8K
PDCO
728
DELISTED
Patterson Companies, Inc.
PDCO
$14.4M 0.01%
363,695
+53,228
+17% +$2.15M
TEN
729
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$14.3M 0.01%
218,356
-12,858
-6% -$797K
CBST
730
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$14.3M 0.01%
204,103
-11,892
-6% -$809K
BB icon
731
BlackBerry
BB
$4.98B
$14.1M 0.01%
1,370,482
+174,153
+15% +$1.37M
ULTI
732
DELISTED
Ultimate Software Group Inc
ULTI
$14.1M 0.01%
101,712
-9,701
-9% -$1.23M
CUBE icon
733
CubeSmart
CUBE
$9.39B
$14M 0.01%
766,557
+279,628
+57% +$5.09M
RJF icon
734
Raymond James Financial
RJF
$33.8B
$13.9M 0.01%
411,474
+15,832
+4% +$528K
UAL icon
735
United Airlines
UAL
$39.4B
$13.9M 0.01%
337,910
+8,908
+3% +$384K
AEGR
736
DELISTED
Aegerion Pharmaceuticals
AEGR
$13.8M 0.01%
429,363
+51,786
+14% +$1.93M
DEI icon
737
Douglas Emmett
DEI
$1.98B
$13.6M 0.01%
482,339
+75,000
+18% +$2.09M
BP icon
738
BP
BP
$116B
$13.6M 0.01%
315,307
+19,427
+7% +$801K
SAN icon
739
Banco Santander
SAN
$201B
$13.3M 0.01%
1,403,221
+137,856
+11% +$1.27M
LSI
740
DELISTED
Life Storage, Inc.
LSI
$13.2M 0.01%
257,037
+192,622
+299% +$9.75M
VRNT
741
DELISTED
Verint Systems
VRNT
$13.2M 0.01%
528,905
+487,293
+1,171% +$11.5M
NBIX icon
742
Neurocrine Biosciences
NBIX
$16.8B
$13.2M 0.01%
889,898
ABG icon
743
Asbury Automotive
ABG
$4.31B
$13.2M 0.01%
191,467
-19,776
-9% -$1.22M
HBAN icon
744
Huntington Bancshares
HBAN
$34.4B
$13.1M 0.01%
1,367,920
+78,248
+6% +$736K
ERF
745
DELISTED
Enerplus Corporation
ERF
$13M 0.01%
519,496
+27,923
+6% +$618K
AMCX icon
746
AMC Global Media
AMCX
$492M
$12.7M 0.01%
207,131
-14,600
-7% -$934K
CTCT
747
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$12.7M 0.01%
396,273
+288,874
+269% +$8.05M
AIV
748
Aimco
AIV
$387M
$12.7M 0.01%
2,957,306
+21,267
+0.7% +$88K
PPS
749
DELISTED
Post Properties
PPS
$12.7M 0.01%
237,202
+39,800
+20% +$2.04M
GTLS
750
DELISTED
Chart Industries
GTLS
$12.6M 0.01%
152,816
-10,724
-7% -$812K

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.